Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥7,730 JPY
Change Today -20.00 / -0.26%
Volume 13.7K
As of 1:00 AM 11/27/15 All times are local (Market data is delayed by at least 15 minutes).

mochida pharmaceutical co (4534) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/28/15 - ¥8,340
52 Week Low
01/13/15 - ¥6,180
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MOCHIDA PHARMACEUTICAL CO (4534)

Related News

No related news articles were found.

mochida pharmaceutical co (4534) Related Businessweek News

No Related Businessweek News Found

mochida pharmaceutical co (4534) Details

Mochida Pharmaceutical Co., Ltd. produces and sells pharmaceutical and skin care products in Japan. It provides cardiovascular agents comprising Epadel for arteriosclerosis obliterans and hyperlipidemia; Atelec and Atedio for hypertension; Rocornal for angina pectoris; and Treprost for pulmonary arterial hypertension, as well as analgesic agents, including Tramcet for chronic pain and tooth extraction pain. The company also offers antidiabetes agents, such as Fastic for diabetes; neurological agents, including Lexapro and Tecipul for depression, and Grandaxin for autonomic dystonia; and anti-infectives, such as Florid for mycosis, Isoprinosine for subacute sclerosing panencephalitis, Beselna for condyloma acuminatum, and Francetin, an antibiotic, as well as Arasena-A for herpes zoster, herpes simplex, and herpes simplex encephalitis. In addition, it provides hormone preparations comprising Dinagest for endometriosis; Divigel for menopausal symptoms; Suprecur for endometriosis, precocious puberty, and uterine myoma; Desopan, an antiadrenal cortical hormone; Ortho 777-21/M-21, an oral contraceptive; Estriel for hormone replacement therapy and osteoporosis; and HCG Mochida, a human chorionic gonadotrophin injection. Further, the company offers biological preparations, such as Miraclid for acute circulatory failure and pancreatitis; Thrombin, a hemostatic agent; Heparin sodium injection for thrombosis; and Uronase for acute myocardial infarction, as well as biosimilars for neutropenia. Additionally, it provides diagnostic reagents for fertility/infertility, as well as CanD-Tec, a candida antigen detection test; face and body care, and hair care products; nutraceuticals; baby care products comprising bath oils, skin cleansers, and shampoos; and contract manufacturing services. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.

1,746 Employees
Last Reported Date: 06/26/15
Founded in 1913

mochida pharmaceutical co (4534) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

mochida pharmaceutical co (4534) Key Developments

Mochida Pharmaceutical Co. Ltd., Q2 2016 Earnings Call, Nov 05, 2015

Mochida Pharmaceutical Co. Ltd., Q2 2016 Earnings Call, Nov 05, 2015

Mochida Pharmaceutical Co. Ltd. to Report Q2, 2016 Results on Oct 30, 2015

Mochida Pharmaceutical Co. Ltd. announced that they will report Q2, 2016 results on Oct 30, 2015

Mochida Pharmaceutical Co. Ltd. to Report Q1, 2016 Results on Jul 31, 2015

Mochida Pharmaceutical Co. Ltd. announced that they will report Q1, 2016 results on Jul 31, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4534:JP ¥7,730.00 JPY -20.00

4534 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4534.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4534 Industry Range
Price/Earnings 16.2x
Price/Sales 1.7x
Price/Book 1.5x
Price/Cash Flow 16.2x
TEV/Sales 1.1x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MOCHIDA PHARMACEUTICAL CO, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at